Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

12.43 +0.52 (+4.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Why Is Huadi International (HUDI) Stock Up 30% Today?
Huadi International (HUDI) stock is climbing higher on Thursday even without specific news from the Chinese steel company. 
Via InvestorPlace
Why Is Magic Empire Global (MEGL) Stock Up 83% Today?
Magic Empire Global (MEGL) stock is rocketing higher on Thursday despite a lack of news from the Hong Kong financial services provider. 
Via InvestorPlace
NovoCure (NVCR) Stock Soars 50% on Positive Clinical Trial Results
NVCR stock traders are undeniably pleased to see NovoCure marking a milestone in the company's quest to treat a specific type of lung cancer. 
Via InvestorPlace
Why Novocure Stock Is Skyrocketing Today
The company announced good news from a late-stage study of its Tumor Treating Fields therapy. 
Via The Motley Fool
Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients
 
Via Benzinga
This Good News on Cancer Sent 2 Nasdaq Stocks Soaring
Biotech investors are optimistic about the prospects for a potential treatment. 
Via The Motley Fool
Novocure Skyrockets After Pulling Off A Once-In-Six-Years Feat
The company is now planning to ask for FDA approval in the second half of 2023. 
Via Investor's Business Daily
Where NovoCure Stands With Analysts
 
Via Benzinga
Why Novocure Stock Is Jumping Today
Novocure's innovative cancer therapy picked up a big win in Canada. 
Via The Motley Fool
US Stocks Open Lower; Dow Tumbles 300 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 300 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
From Zai Lab Limited
Via GlobeNewswire
Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
From Novocure
Via Business Wire
5 Analysts Have This to Say About NovoCure
 
Via Benzinga
Novocure Stock: Bull vs. Bear
The company's technology has a lot of potential. But does its stock? 
Via The Motley Fool
Novocure to Participate in 41st Annual J.P. Morgan Healthcare Conference
From Novocure
Via Business Wire
3 Stocks That Could Soar in a Santa Claus Rally
These stocks are primed for a holiday surge. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
3 Top Stocks to Buy Hand Over Fist Before the End of 2022
You probably shouldn't wait for long to buy these stocks. 
Via The Motley Fool
5 Top Stocks for December
From game-changing products to indisputable growth catalysts, this list of top stocks has something for all. 
Via The Motley Fool
12 Top Stocks to Buy in December
Add this dandy dozen to your stocking this month. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
 
Via Benzinga
Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
From Novocure
Via Business Wire
FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday
Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in... 
Via Benzinga
3 Growth Stocks to Buy That Could Skyrocket
The future looks promising for all three of these stocks. 
Via The Motley Fool
Novocure to Participate in 34th Annual Piper Sandler Healthcare Conference
From Novocure
Via Business Wire
Novocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual Meeting
From Novocure
Via Business Wire
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
From Novocure
Via Business Wire
Novocure Secures CE Mark for New Array
From Novocure
Via Business Wire
2 Potentially Explosive Stocks to Buy in November
Both Novocure and MercadoLibre could have good news on the way. 
Via The Motley Fool
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.